Does Rallies show 13F holders for RPTX?

Yes. Rallies tracks hedge fund and 13F ownership data for RPTX, including fund names, share counts, latest tracked quarter, and position changes when available.

Is RPTX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for RPTX. It does not provide personalized investment advice.

RPTX (Repare Therapeutics Inc. Common Shares) Stock Analysis - Hedge Fund Holdings

Repare Therapeutics Inc. Common Shares (RPTX) is a publicly traded Healthcare sector company. As of May 21, 2026, RPTX trades at $2.65 with a market cap of $114.24M and a P/E ratio of -1.19. RPTX moved +0.38% today. Year to date, RPTX is +46.41%; over the trailing twelve months it is +130.44%. Its 52-week range spans $0.89 to $4.07. Analyst consensus is buy with an average price target of $3.00. Rallies surfaces RPTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns RPTX stock?

Hedge funds tracked by Rallies that own RPTX include Orbimed Advisors and Redmile Group. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Repare Therapeutics Inc. Common Shares.

RPTX Key Metrics

Key financial metrics for RPTX
Metric	Value
Price	$2.65
Market Cap	$114.24M
P/E Ratio	-1.19
EPS	$-2.23
Dividend Yield	0.00%
52-Week High	$4.07
52-Week Low	$0.89
Volume	1.22M
Avg Volume	0
Revenue (TTM)	$51.13M
Net Income	$-93.80M
Gross Margin	0.00%

Top Hedge Funds Holding RPTX

Orbimed Advisors holds 3.32M shares of RPTX, changed +0.00% as of Dec 31, 2025.
Redmile Group holds 1.59M shares of RPTX, changed +0.00% as of Dec 31, 2025.

Latest RPTX News

Repare Therapeutics Shareholders Approve 99.76% Vote for XenoTherapeutics Acquisition — Jan 16, 2026

Recent RPTX Insider Trades

Koehler Maria sold 3.60K (~$4.10K) on Mar 12, 2025.
Zinda Michael sold 5.61K (~$6.40K) on Mar 12, 2025.
Forte Steve sold 6.88K (~$7.85K) on Mar 12, 2025.

RPTX Analyst Consensus

9 analysts cover RPTX: 0 strong buy, 7 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.00.

Common questions about RPTX

Who owns RPTX stock?: Hedge funds tracked by Rallies that own RPTX include Orbimed Advisors and Redmile Group. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Repare Therapeutics Inc. Common Shares.
Does Rallies show 13F holders for RPTX?: Yes. Rallies tracks hedge fund and 13F ownership data for RPTX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is RPTX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for RPTX. It does not provide personalized investment advice.